Protective Effects of Curcumin and Quercetin Against Vancomycin-Induced Acute Kidney Injury in Rats
Vancomycin (VCM) is an essential antibiotic for severe Gram-positive infections; however, its clinical use is frequently complicated by acute kidney injury (AKI). Oxidative stress, inflammation, and apoptosis are important mechanisms underlying VCM-induced renal injury. This study investigated the potential ameliorative effects of curcumin (CUR), quercetin (QUR), and their combination against VCM-induced AKI. Twenty-five male albino rats (100–130 g) were randomly divided into five groups (n = 5): control, VCM, CUR+VCM, QUR+VCM, and CUR+QUR+VCM. CUR and QUR (100 mg/kg each) were administered orally by gavage in 0.2 mL of olive oil for 14 consecutive days, while VCM (400 mg/kg, i.p.) was administered from days 8 to 14. Renal function and injury were assessed by serum creatinine, urea, cystatin C, and KIM-1. Renal MDA, NO, GSH, SOD, and CAT were evaluated, together with TNF-α, IL-6, IL-1β, Bax, Bcl-2, and caspase-3. Renal Nrf2 immunoreactivity and histopathological alterations were also examined. VCM significantly impaired renal function, increased renal MDA, NO, TNF-α, IL-6, IL-1β, Bax, and caspase-3, and decreased GSH, SOD, CAT, Bcl-2, and Nrf2 immunoreactivity. These biochemical and molecular disturbances were accompanied by marked tubular degeneration, vacuolation, luminal dilation, and vascular congestion. CUR and QUR significantly attenuated these alterations, while their combined administration produced the most pronounced improvement across renal biomarkers, oxidative/antioxidant status, inflammatory and apoptotic markers, Nrf2 expression, and renal architecture. CUR and QUR exerted significant protective effects against VCM-induced AKI, potentially through coordinated restoration of antioxidant defense, attenuation of inflammation and apoptosis, and preservation of renal tissue integrity. Their combined administration demonstrated higher renoprotective activity, supporting further investigation of this combination as a potential strategy for mitigating VCM-associated nephrotoxicity.
Authors
- Mohamed Salah Basiouny (ORCID: https://orcid.org/0009-0003-7894-6111)
- Laila Abdullah Damiati (ORCID: https://orcid.org/0000-0002-4746-0915)
- Ahmed Abd Elbadee
- Mohamed H. A. Gadelmawla (ORCID: https://orcid.org/0000-0002-1976-9480)
- Khaled Abuelhaded (ORCID: https://orcid.org/0009-0004-8130-730X)
- Khaled M. Alam-ElDein (ORCID: https://orcid.org/0009-0002-1140-8338)
- Haneen Osama
- Ahmed A. Aly
- Ainour Sherif
- Dina Amr
- Joudy Hassan
- Ganna Mohamed
- Habiba Tarek
Institutions
- Qassim University (SA)
- University of Sadat City (EG)
- University of Jeddah (SA)
- Badr University in Cairo (EG)
- Aswan University (EG)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-11-20
- DOI
- https://doi.org/10.3390/ijms272210462
- Primary Topic
- Chemotherapy-induced organ toxicity mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00